Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ILIT for Allergic Rhinitis (House Dust Mite, Cat, Dog)
NCT02269566Phase 1Terminated
- Sponsor
- Gachon University Gil Medical Center
- Start
- Aug 2014
- Primary completion
- Feb 2016
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of HollisterStier allergen extracts in allergic rhinitis (AR) (2 arms), sponsored by Gachon University Gil Medical Center. Primary endpoint: Rhinoconjunctivitis Quality of Life Questionnaire at 12 months. Started Aug 2014; status: terminated.
02
Drugs
HollisterStier allergen extracts
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on NCT02269566.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02269566.